MUC16 Juxtamembrane Domain-Binding Peptides for Imaging and Therapy of Ovarian Cancer
Abstract
The goal of the project was the selection and identification of peptide ligands with high affinity to the MUC16 juxtamembrane domain. During ovarian cancer tumorigenesis, the MUC16 (CA-125) ectodomain is often shed leaving a short juxtamembrane (JMD) peptide protruding into the extracellular space. This epitope represents an attractive target for targeted molecular imaging and radiotherapy of ovarian cancer.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2023
- Accession Number
- AD1219341
Entities
People
- Steven W Millward
Organizations
- The University of Texas MD Anderson Cancer Center